The Group made an initial public offering on 24 May 2006 and was listed on the main Board of the Stock Exchange of Hong Kong Limited on June 6, 2006 (stock code: 474.HK).
The Group is a comprehensive investment group. On the basis of diversified investment, the Group will focus on the development of life science and technology industry in the future, lay out the key areas and technologies for the future development of human life science, and invest in incubating the world's leading life science and technology companies. to create the world's leading life science research platform. At the same time, by incubating the overseas exclusive management rights with the leading pharmaceutical enterprises in Greater China, the overseas leading technology will be landed in China and Southeast Asian countries. Through a diversified and sound business model, the Group creates ideal returns for the majority of investors.
In addition, the Group controls Haotian International Construction Investment Group Co., Ltd. ("Haotian International Construction, 1341.HK"). As at 31 March 2020, the total assets of the Group exceeded HK $5 billion.
Market： Hong Kong motherboard
Listing Date： 06/06/2006